NASDAQ
KERN

Akerna Corp

Health Information Services
Healthcare

Prices are adjusted according to historical splits.

Akerna Corp Stock Price

Vitals

Today's Low:
$0.317
Today's High:
$0.3769
Open Price:
$0.3686
52W Low:
$0.26
52W High:
$4.762
Prev. Close:
$0.385
Volume:
1347006

Company Statistics

Market Cap.:
$2.35 million
Book Value:
-1.442
Revenue TTM:
$10.80 million
Operating Margin TTM:
-93.74%
Gross Profit TTM:
$8.23 million
Profit Margin:
0%
Return on Assets TTM:
-25.53%
Return on Equity TTM:
-943.66%

Company Profile

Akerna Corp had its IPO on 2018-02-26 under the ticker symbol KERN.

The company operates in the Healthcare sector and Health Information Services industry. Akerna Corp has a staff strength of 112 employees.

Stock update

Shares of Akerna Corp opened at $0.37 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.32 - $0.38, and closed at $0.34.

This is a -11.69% slip from the previous day's closing price.

A total volume of 1,347,006 shares were traded at the close of the day’s session.

In the last one week, shares of Akerna Corp have increased by +12.96%.

Akerna Corp's Key Ratios

Akerna Corp has a market cap of $2.35 million, indicating a price to book ratio of 0.2303 and a price to sales ratio of 0.157.

In the last 12-months Akerna Corp’s revenue was $10.80 million with a gross profit of $8.23 million and an EBITDA of $-11271498. The EBITDA ratio measures Akerna Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Akerna Corp’s operating margin was -93.74% while its return on assets stood at -25.53% with a return of equity of -943.66%.

In Q2, Akerna Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 34.4%.

Akerna Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0.0968
PEG

Its diluted EPS in the last 12-months stands at $3.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Akerna Corp’s profitability.

Akerna Corp stock is trading at a EV to sales ratio of 0.7308 and a EV to EBITDA ratio of -1.5847. Its price to sales ratio in the trailing 12-months stood at 0.157.

Akerna Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$6.41 million
Total Liabilities
$12.08 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Akerna Corp ended 2024 with $6.41 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.41 million while shareholder equity stood at $-8162393.00.

Akerna Corp ended 2024 with $0 in deferred long-term liabilities, $12.08 million in other current liabilities, 700.00 in common stock, $-173122425.00 in retained earnings and $1.71 million in goodwill. Its cash balance stood at $828133.00 and cash and short-term investments were $828133.00. The company’s total short-term debt was $7,770,543 while long-term debt stood at $2.49 million.

Akerna Corp’s total current assets stands at $2.41 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $749127.00 compared to accounts payable of $1.75 million and inventory worth $604526.00.

In 2024, Akerna Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Akerna Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.34
52-Week High
$4.762
52-Week Low
$0.26
Analyst Target Price
$0.8

Akerna Corp stock is currently trading at $0.34 per share. It touched a 52-week high of $4.762 and a 52-week low of $4.762. Analysts tracking the stock have a 12-month average target price of $0.8.

Its 50-day moving average was $0.47 and 200-day moving average was $0.78 The short ratio stood at 0.29 indicating a short percent outstanding of 0%.

Around 1950.1% of the company’s stock are held by insiders while 347.9% are held by institutions.

Frequently Asked Questions About Akerna Corp

The stock symbol (also called stock or share ticker) of Akerna Corp is KERN

The IPO of Akerna Corp took place on 2018-02-26

Similar Industry Stocks (Health Information Services)

Last Price
Chg
Chg%
$9.53
0
0%
$17068.5
-209.65
-1.21%
Dana Inc (DAN)
$15.87
0.37
+2.39%
$121.15
-13
-9.69%
$219.94
-2.51
-1.13%
$0.42
0.02
+5%
$5.95
-0.19
-3.09%
$3.23
0.08
+2.54%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

Address

1550 Larimer Street, Denver, CO, United States, 80202